SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
- Yu An Zhang
- , Yunyun Zhou
- , Xin Luo
- , Kai Song
- , Xiaotu Ma
- , Adwait Sathe
- , Luc Girard
- , Guanghua Xiao
- , Adi F. Gazdar
- University of Texas Southwestern Medical Center
- Tianjin University
- St. Jude Children Research Hospital
- University of Texas at Dallas
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations